Home/ Stocks/ HOTH

Hoth Therapeutics, Inc. Common Stock

HOTH XNAS

$0.89 -0.04 (-4.63%) ▼ 15-min delayed

Open

$0.93

High

$0.93

Low

$0.88

Volume

567.2K

Market Cap

$14.48M

About Hoth Therapeutics, Inc. Common Stock

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 3 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-4,105,801	$-0.30
Q2 2025	$0	$-2,199,476	$-0.17
Q1 2025	$0	$-3,475,836	$-0.27
FY 2024	$0	$-8,188,300	$-1.28

Related Market News

No specific coverage for HOTH yet. Check out our latest market news or earnings calendar.

Get HOTH Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Hoth Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.